Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Pfizer buys Amplyx to expand drug-resistant treatment portfolio
Pfizer buys Amplyx to expand drug-resistant treatment portfolio
Pfizer Inc (PFE.
U.S. drugmakers step up supplies as India battles COVID-19 surge
U.S. drugmakers step up supplies as India battles COVID-19 surge
U.
Israel Examines Heart Inflammation Cases After Pfizer Shot
Israel Examines Heart Inflammation Cases After Pfizer Shot
Israel is examining dozens of cases where people experienced heart inflammation after receiving Pfizer Inc.
FDA to scrutinize unproven cancer drugs after 10-year gap
FDA to scrutinize unproven cancer drugs after 10-year gap
WASHINGTON — Each year the U.
J&J COVID-19 vaccine hold lifted in the US
J&J COVID-19 vaccine hold lifted in the US
The rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine can resume in the US after regulatory authorities approved to lift the hold placed on the jab, following concerns over very ...
Tagrisso recommended for approval in the EU by CHMP for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Tagrisso recommended for approval in the EU by CHMP for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
LONDON, UK I April 26, 2021 I AstraZeneca’s Tagrisso (osimertinib) has been recommended for marketing authorisation in the European Union for the adjuvant treatment of adult patients with ea...
Coloured compounds may help coronavirus evade antibodies
Coloured compounds may help coronavirus evade antibodies
Researchers have uncovered how two coloured compounds, called biliverdin and bilirubin, bind to the spike proteins on the surface of the SARS-CoV-2 coronavirus, effectively blocking antibodies from bi...
Experimental drug shows potential against Alzheimer's disease
Experimental drug shows potential against Alzheimer's disease
Researchers at Albert Einstein College of Medicine have designed an experimental drug that reversed key symptoms of Alzheimer's disease in mice.
EU concluding deal for 1.8 billion more BioNTech-Pfizer vaccine doses
EU concluding deal for 1.8 billion more BioNTech-Pfizer vaccine doses
Brussels says its third contract with the US-German vaccine consortium is the world's largest supply deal so far to stem the coronavirus' spread.
Eight new medicines recommended for approval
Eight new medicines recommended for approval
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2021 meeting.
Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse
Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse
Evotec SE (Frankfurt Stock Exchange.
FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines
Statement From.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand